Forthcoming Anti-Trans Report From HHS Could Further Restrict Access to Care
The White House released a fact sheet Monday confirming it will declare gender-affirming care “not supported” by evidence in a new, pseudoscientific report — contradicting numerous peer-reviewed studies demonstrating positive outcomes. The document reveals the administration will meet the 90-day deadline set by Trump’s first executive order, with language suggesting the forthcoming report will abandon scientific objectivity. More ominously, the fact sheet discloses that investigations into providers and hormone replacement therapy manufacturers have already begun, potentially threatening medication access for transgender Americans within months. The moves signal what appears to be the administration’s latest salvo against transgender rights.
“Section 3(ii) directs HHS to publish an evidence-based review of the literature on best-practices to promote the health of children who assert gender dysphoria. HHS has coordinated with a team of eight distinguished scholars, and will publish this review by the 90-day deadline,” reads the fact sheet.
Previous reporting by Erin In The Morning confirmed that this report was expected. The review is expected to follow the same playbook as Governor DeSantis’ Florida Board of Medicine review and the........
© Truthout
